title: Effect of brain stem NMDA-receptor blockade by MK-801 on behavioral and fos responses to vagal satiety signals.
abstract: To test the possible role of N-methyl-D-aspartate (NMDA) glutamate receptors in the transmission of gastrointestinal satiety signals at the level of the nucleus of the solitary tract (NTS), we assessed the effect of fourth ventricular infusion of the noncompetitive NMDA receptor antagonist MK-801 on short-term sucrose intake and on gastric distension-induced Fos expression in the dorsal vagal complex of unanesthetized rats. MK-801, although not affecting initial rate of intake, significantly increased sucrose intake during the later phase of the meal (10-30 min, 8.9 +/- 1.0 vs. 2.9 +/- 0.8 ml, P < 0.01). In the medial subnucleus of the NTS, the area postrema, and the dorsal motor nucleus, MK-801 did not reduce gastric distension-induced Fos expression and itself did not significantly induce Fos expression. In the dorsomedial, commissural, and gelatinosus subnuclei, MK-801 in itself produced significant Fos expression and significantly reduced (-75%, P < 0.05) the ability of gastric distension to induce Fos expression, assuming an additive model with two separate populations of neurons activated by distension and the blocker. Although these results are consistent with NMDA receptor-mediated glutamatergic transmission of vagal satiety signals in general, they lend limited support for such a role in the transmission of specific gastric distension signals.
authors.affiliation: Neurobiology of Nutrition Laboratory, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana 70808, USA.
authors.forename: H
authors.initials: H
authors.lastname: Zheng
authors.forename: L
authors.initials: L
authors.lastname: Kelly
authors.forename: L M
authors.initials: LM
authors.lastname: Patterson
authors.forename: H R
authors.initials: HR
authors.lastname: Berthoud
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001933:Brain Stem / Q000378:metabolism*; D002404:Catheterization; D016291:Dizocilpine Maleate / Q000494:pharmacology*; D004326:Drinking; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology*; D007276:Injections, Intraventricular; D008297:Male; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D012528:Satiety Response / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology; D017552:Solitary Nucleus / Q000378:metabolism; D012996:Solutions; D013270:Stomach / Q000502:physiology; D013395:Sucrose; D014630:Vagus Nerve / Q000502:physiology*
chemical_list: D018691:Excitatory Amino Acid Antagonists; D016760:Proto-Oncogene Proteins c-fos; D016194:Receptors, N-Methyl-D-Aspartate; D012996:Solutions; D013395:Sucrose; D016291:Dizocilpine Maleate